99% Purity CAS 32986-56-4 Tobramycin Antibacterial Tobramycin Powder Tobramycin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Tobramycin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Tobramycin
• Name: Tobramycin Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antibacterial
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 32986-56-4
• Mf: C18h37n5o9
• MW: 467.52
• Density: 1.52
• Melting Point: 178 °c
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

99% Purity CAS 32986-56-4 Tobramycin Antibacterial Tobramycin Powder Tobramycin

Product Description

Product Details

Product name	Tobramycin
Cas number	32986-56-4
Apperance	White powder
Density	1.52
MF	C18H37N5O9
Melting point	178 °C
MW	467.52

Tobramycin is an aminoglycoside antibiotic used to treat various types of bacterial infections, particularly Gram-negative infections. Tobramycin, an aminoglycoside antibiotic, has almost the same antibacterial spectrum as Gentamycin, but enjoys lower nephrotoxicity and otoxicity than Gentamycin. It has high antibacterial activity in Gram-negative bacteria, especially against Pseudomonas  areuginosa. Besides, it exerts synergic effect in combination with Penicillins or Cephalosporins.

Application&Function

This product is suitable for Pseudomonas aeruginosa, Proteus (indole positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and Staphylococcus (including penicillin G and methicillin resistant strains) Neonatal sepsis, sepsis, central nervous system infections (including meningitis), genitourinary system infections, lung infections, biliary tract infections, abdominal cavity infections (and peritonitis), bone infections, skin and soft tissue infections (including burns) ), acute and chronic otitis media, sinusitis, etc. When used for Pseudomonas aeruginosa meningitis or ventriculitis, the product can be administered by intrathecal injection at the same time; when used for bronchial and lung infections, the product can be inhaled simultaneously as an adjuvant treatment. Tobramycin is ineffective against most group D streptococcal infections. It is effective for conjunctivitis, keratitis and other eye bacterial infections, especially Gram-negative bacterial infections resistant to gentamicin, such as severe Pseudomonas aeruginosa infections.

Specification